CHG HealthcareEndocrinologist Needed in Colorado CHG HealthcareEndocrinologist Needed in ColoradoPueblo, COYour specialty-specific CompHealth rep places your best interests at the heart of everything they do and pays careful attention to the things that matter to you, from the big, hard-to-solve problems to the tiniest details. This waterfront town has museums, a zoo, access to beautiful national forests, a historic Riverwalk, whitewater kayaking, a nature center, multiple bike trails, and a university.
Colorado West Healthcare SystemEndocrinologist - Underserved Community Need Colorado West Healthcare SystemEndocrinologist - Underserved Community NeedGrand Junction, COPart timeIn 2024, Community Hospital earned the prestigious 5-star quality rating from Centers for Medicare and Medicaid Services (CMS) and was recognized by Becker’s Healthcare as one of Colorado’s top recommended hospitals. With over 300 days of sunshine per year, 1.5 million acres to explore and 76 percent of the area being public land, Grand Junction boasts unforgettable Colorado experiences without the crowds.
Vail HealthEndocrinologist Vail HealthEndocrinologistAvon, COWork with clinical team comprised of registered nurses, certified diabetes educator, advanced practice provider and care tech in addition to providing coverage as needed with physicians partners. Knowledge/interest/expertise in the advanced management of all forms of diabetes mellitus, including skilled interpretation of data from and use of insulin pumps and continuous glucose sensors.
Taylor Strategy PartnersSpecialty Sales Representative – Cardiometabolic Rare Disease Taylor Strategy PartnersSpecialty Sales Representative – Cardiometabolic Rare DiseaseDenver, CORemote$160,000–$180,000 / yearThis is a unique opportunity to play a meaningful role in the launch and growth of our cardiometabolic portfolio, including Plozasiran (siRNA targeting APOC3), developed for patients with rare and high-need cardiovascular conditions such as Familial Chylomicronemia Syndrome (FCS) and Severe Hypertriglyceridemia (SHTG). Arrowhead is leading the field in bringing the promise of RNAi to address diseases outside of the liver, and our clinical pipeline includes disease targets in the liver and lung with a promising pipeline of preclinical candidates.